Monday | Dec 23 2024 |

Articles for affordable therapy

Zydus Secures COFEPRIS Approval For Mamitra, Trastuzumab Biosimilar To Combat Multiple Cancers

Healthcare Service Providers Aug 01, 2024 1 mins read

This new approval allows Mamitra to be marketed in strengths of 150 mg and 440 mg, targeting HER2 overexpressing metastatic breast cancer (MBC), HER2 overexpressing early breast cancer (EBC), and advanced gastric cancer

Read More

BW TV

Thursday Thought Leaders with Harbinder Narula | In Conversation with Prabhdeep Singh | Episode - 11

Inhouse

Feb 23, 2023

Thursday Thought Leaders with Harbinder Narula | In Conversation with Prabhdeep Singh | Episode - 11

All You Wanted to Know About Down Syndrome, On World Down Syndrome Day

Inhouse

Mar 21, 2022

All You Wanted to Know About Down Syndrome, On World Down Syndrome Day

Breast Cancer - Challenges & Possibilities in Conversation with Dr. Kanchan Kaur

Inhouse

Mar 04, 2022

Breast Cancer - Challenges & Possibilities in Conversation with Dr. Kanchan Kaur

Dr. Sharda Jain Shares Her Concern on Cervical Cancer Challenge in India on World Cancer Day

Inhouse

Feb 04, 2022

Dr. Sharda Jain Shares Her Concern on Cervical Cancer Challenge in India on World Cancer Day

Dr. Kanchan Kaur of Medanta Expresses Herself on World Cancer Day

Inhouse

Feb 04, 2022

Dr. Kanchan Kaur of Medanta Expresses Herself on World Cancer Day

Vivek Srivastava of HCAH on Expectations For Indian Healthcare in 2022

Inhouse

Jan 19, 2022

Vivek Srivastava of HCAH on Expectations For Indian Healthcare in 2022

The benefits of ‘Time in Range’ for Holistic Diabetes Management

Inhouse

Jan 19, 2022

The benefits of ‘Time in Range’ for Holistic Diabetes Management

How To Best Prepare for the Third Wave - National Doctors Day

Inhouse

Jul 01, 2021

How To Best Prepare for the Third Wave - National Doctors Day

Subscribe to our newsletter to get updates on our latest news